Neuroendocrine influences on cancer progression

During the past decade, new studies have continued to shed light on the role of neuroendocrine regulation of downstream physiological and biological pathways relevant to cancer growth and progression. More specifically, our knowledge of the effects of the sympathetic nervous system (SNS) on cancer biology has been greatly expanded by new data demonstrating how the cellular immune response, inflammatory processes, tumor-associated angiogenesis, and tumor cell invasion and survival converge to promote tumor growth. This review will summarize these studies, while synthesizing clinical, cellular and molecular research that has continued to unearth the biological events mediating the interplay between SNS-related processes and cancer progression.

[1]  R. Pollock,et al.  Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. , 1991, Archives of surgery.

[2]  M. Caron,et al.  Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Otten,et al.  Personality factors and breast cancer risk: a 13-year follow-up. , 2008, Journal of the National Cancer Institute.

[4]  Timothy R. Crespin,et al.  Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments , 2007, Brain, Behavior, and Immunity.

[5]  George Kulik,et al.  Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation* , 2007, Journal of Biological Chemistry.

[6]  B. Flaxman,et al.  In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. , 1975, The Journal of investigative dermatology.

[7]  A. Sood,et al.  Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth , 2011, Clinical Cancer Research.

[8]  C. Shapiro,et al.  Biobehavioral, Immune, and Health Benefits following Recurrence for Psychological Intervention Participants , 2010, Clinical Cancer Research.

[9]  J. Bos,et al.  Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor , 2003, The Journal of cell biology.

[10]  R. MacCallum,et al.  Stress and immune responses after surgical treatment for regional breast cancer. , 1998, Journal of the National Cancer Institute.

[11]  J. Kaprio,et al.  Stressful life events and risk of breast cancer in 10,808 women: a cohort study. , 2003, American journal of epidemiology.

[12]  R. MacCallum,et al.  Hormonal modulation of Epstein-Barr virus replication. , 1995, Neuroendocrinology.

[13]  A. Sood,et al.  Psychosocial factors and interleukin‐6 among women with advanced ovarian cancer , 2005, Cancer.

[14]  B. McEwen Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.

[15]  I. Bairati,et al.  Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada) , 2004, Cancer Causes & Control.

[16]  B. Marchetti,et al.  A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: Hormonal control of β-adrenergic receptors and correlation with tumor growth , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  A. Flahault,et al.  [Could treatments with beta-blockers be associated with a reduction in cancer risk?]. , 2004, Revue d'epidemiologie et de sante publique.

[18]  Liz Y. Han,et al.  Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. , 2008, Journal of the National Cancer Institute.

[19]  Kunhong Xiao,et al.  A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 , 2011, Nature.

[20]  Steve W. Cole,et al.  Neuroendocrine modulation of cancer progression , 2009, Brain, Behavior, and Immunity.

[21]  K. Bennett,et al.  Beta blockers and breast cancer mortality: a population- based study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. During,et al.  Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes Cancer Remission and Inhibition , 2010, Cell.

[23]  F. Entschladen,et al.  Tumor interactions with soluble factors and the nervous system , 2010, Cell Communication and Signaling.

[24]  Steven W. Cole,et al.  Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.

[25]  F. Penedo,et al.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  R. Sun,et al.  β-Adrenoreceptors Reactivate Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication via PKA-Dependent Control of Viral RTA , 2005, Journal of Virology.

[27]  I. Rabinovitz,et al.  Towards a mechanistic understanding of tumor invasion--lessons from the alpha6beta 4 integrin. , 2001, Seminars in cancer biology.

[28]  S. Basu,et al.  Depleted Dopamine in Gastric Cancer Tissues , 2004, Clinical Cancer Research.

[29]  P. McDonald,et al.  The influence of bio-behavioural factors on tumour biology: pathways and mechanisms , 2006, Nature Reviews Cancer.

[30]  David A. Tuveson,et al.  Maximizing mouse cancer models , 2007, Nature Reviews Cancer.

[31]  F. Dhabhar,et al.  Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer , 2009, Brain, Behavior, and Immunity.

[32]  G. Bronnikov,et al.  Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a β-Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2* , 2000, The Journal of Biological Chemistry.

[33]  A. Sood,et al.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  A. Sood,et al.  Vascular endothelial growth factor and social support in patients with ovarian carcinoma , 2002, Cancer.

[35]  C. Carver,et al.  Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study. , 2009, Journal of psychosomatic research.

[36]  J. Bahr,et al.  Norepinephrine in the rat ovary: ontogeny and de novo synthesis. , 1984, Endocrinology.

[37]  J. Cacioppo,et al.  Autonomic and Glucocorticoid Associations with the Steady-State Expression of Latent Epstein–Barr Virus , 2002, Hormones and Behavior.

[38]  S. Lemeshow,et al.  Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. , 2006, Cancer research.

[39]  A. Castrucci,et al.  Catecholamine effects on human melanoma cells evoked by α1-adrenoceptors , 2004, Archives of Dermatological Research.

[40]  F. Penedo,et al.  Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma , 2008, Clinical Cancer Research.

[41]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[42]  S. Lakhani,et al.  Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. , 1999, Cancer research.

[43]  David B Jackson,et al.  Src activation by β-adrenoreceptors is a key switch for tumor metastasis , 2012, Nature Communications.

[44]  S. Ojeda,et al.  Prepubertal ovarian function is finely regulated by direct adrenergic influences. Role of noradrenergic innervation. , 1984, Endocrinology.

[45]  D. Golden-Kreutz,et al.  Psychologic intervention improves survival for breast cancer patients , 2008, Cancer.

[46]  Liz Y. Han,et al.  Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. , 2007, Cancer research.

[47]  Liz Y. Han,et al.  Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. , 2010, The Journal of clinical investigation.

[48]  Stanley Lemeshow,et al.  Chronic stress and susceptibility to skin cancer. , 2005, Journal of the National Cancer Institute.

[49]  D. Mukhopadhyay,et al.  Ablation of Peripheral Dopaminergic Nerves Stimulates Malignant Tumor Growth by Inducing Vascular Permeability Factor/Vascular Endothelial Growth Factor-Mediated Angiogenesis , 2004, Cancer Research.

[50]  M. von Knebel Doeberitz,et al.  Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. , 2003, Cancer research.

[51]  Liz Y. Han,et al.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.

[52]  G. Maestroni Neurohormones and Catecholamines as Functional Components of the Bone Marrow Microenvironment , 2000, Annals of the New York Academy of Sciences.

[53]  Janice A. Nagy,et al.  The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor , 2001, Nature Medicine.

[54]  J. Bos,et al.  Epac proteins: multi-purpose cAMP targets. , 2006, Trends in biochemical sciences.

[55]  J. Kiecolt-Glaser,et al.  Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.

[56]  S. Ojeda,et al.  An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. , 2000, Endocrinology.

[57]  Liz Y. Han,et al.  Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.

[58]  A. Sood,et al.  Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients , 2008, Brain, Behavior, and Immunity.

[59]  T. Seeman,et al.  Computational identification of gene-social environment interaction at the human IL6 locus , 2010, Brain, Behavior, and Immunity.

[60]  A. Sood,et al.  Social support, psychological distress, and natural killer cell activity in ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  P. Butow,et al.  The role of psychosocial factors in the development of breast carcinoma: Part II , 2001, Cancer.

[62]  G. Kunos,et al.  Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. , 1990, Journal of Immunology.

[63]  A. Sood,et al.  Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism* , 2007, Journal of Biological Chemistry.

[64]  A. Sood,et al.  Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis* , 2010, The Journal of Biological Chemistry.

[65]  G. Shakhar,et al.  Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity , 1999, International journal of cancer.

[66]  Anil K Sood,et al.  Impact of stress on cancer metastasis. , 2010, Future oncology.

[67]  G. Hortobagyi,et al.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. Zeegers,et al.  The association between stressful life events and breast cancer risk: A meta‐analysis , 2003, International journal of cancer.

[69]  P. Butow,et al.  The role of psychosocial factors in the development of breast carcinoma: Part I , 2001, Cancer.

[70]  D. Powe,et al.  Targeted therapies: Using β-blockers to inhibit breast cancer progression , 2011, Nature Reviews Clinical Oncology.

[71]  E. Sternberg,et al.  Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.